Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.09)
# 521
Out of 5,131 analysts
370
Total ratings
43.44%
Success rate
15.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $31.56 | +58.43% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $4.08 | +194.12% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $399.40 | +42.71% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $7.62 | +424.93% | 17 | Aug 4, 2025 | |
| ATAI AtaiBeckley | Maintains: Buy | $10 → $15 | $3.97 | +277.83% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $15.89 | -37.07% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $2.51 | +99.20% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.45 | +2,121.24% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.80 | +1,193.10% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $33.05 | +202.57% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $23.15 | +202.38% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.99 | +404.24% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.03 | +1,388.83% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $65.00 | +23.08% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $15.55 | +157.23% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.06 | +638.92% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $37.87 | +84.84% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $28.00 | +185.71% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $2.19 | +356.62% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.50 | +300.00% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $14.70 | +274.15% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.95 | +1,748.74% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $90.01 | -5.57% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.18 | +458.29% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $147.67 | +130.24% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $31.56
Upside: +58.43%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $4.08
Upside: +194.12%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $399.40
Upside: +42.71%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $7.62
Upside: +424.93%
AtaiBeckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $3.97
Upside: +277.83%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $15.89
Upside: -37.07%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $2.51
Upside: +99.20%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.45
Upside: +2,121.24%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $5.80
Upside: +1,193.10%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $33.05
Upside: +202.57%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $23.15
Upside: +202.38%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.99
Upside: +404.24%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.03
Upside: +1,388.83%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $65.00
Upside: +23.08%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $15.55
Upside: +157.23%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.06
Upside: +638.92%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $37.87
Upside: +84.84%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $28.00
Upside: +185.71%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $2.19
Upside: +356.62%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $2.50
Upside: +300.00%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $14.70
Upside: +274.15%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.95
Upside: +1,748.74%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $90.01
Upside: -5.57%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.18
Upside: +458.29%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $147.67
Upside: +130.24%